Image
09.03.2023
Inside the lab: Kidney cell conversations
Each year we invest more than £6 million into life-changing diabetes research. This World Kidney Day on 9...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more